Search Results 2191-2200 of 13643 for monoclonal antibody

  1. Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy - Mayo Clinic

    6 antibody, calicheamicin derivatives or other ingredients. Participation in other studies involving investigational drug(s) (Phases 1-4) during study ...

  2. A Study Of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy In Patients With Multiple Myeloma Following Autologous Stem Cell Transplant - Mayo Clinic

    Diagnosis of Waldenstrom's macroglobulinemia, POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome, plasma ...

  3. JAB-3312 Based Combination Therapy In Adult Patients With Advanced Solid Tumors - Mayo Clinic

    ... antibodies. Note: Testing for seropositive status during Screening ... Note: Participants who are hepatitis C virus antibody positive (HCV Ab+) who ...

  4. Biomarker Serum Biobank for Glomerular Disease - Mayo Clinic

    The purposee of this study is to identify patients with biopsy-proven renal diseases that might have antibodies directed against kidney-antigens, or other ...

  5. Medical Research & Education - Mayo Clinic News Network

    Is the definition of Alzheimer's disease changing? Dana Sparks. November 6, 2018. Mayo researchers correlate specific antibody with relapse of neurological ...

  6. Medical Research & Education - Mayo Clinic News Network

    Is the definition of Alzheimer's disease changing? Dana Sparks. November 6, 2018. Mayo researchers correlate specific antibody with relapse of neurological ...

  7. AB-2100, An Integrated Circuit T (ICT) Cell Therapy In Patients With Recurrent Clear-cell Renal Cell Carcinoma (CcRCC) - Mayo Clinic

    ... antibody-based agent). * Systemic anti-cancer therapy within 14 days of starting of conditioning chemotherapy (interval of 28 days will be required if the ...

  8. A Study To Evaluate Safety Of Long-term AL001 Dosing In FTD Patients - Mayo Clinic

    Participation eligibility · Known history of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric, human, or humanized antibodies or ...

  9. Multi-center, Open-label, Single-ascending Dose Study Of Safety And Tolerability Of TN-201 In Adults With Symptomatic MYBPC3 Mutation-associated HCM - Mayo Clinic

    * High AAV9 neutralizing antibody titer. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 01/28/2026. Questions ...

  10. Amyotrophic Lateral Sclerosis (ALS) Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine the safety and efficacy of intrathecal treatment delivered to the cerebrospinal fluid (CSF) of mesenchymal stem cells ...